Newswise COVID Experts

Filters close

Showing results

110 of 8398
2-Dec-2022 8:05 AM EST
Symptoms of long Covid in children may change over time
University College London

New symptoms may appear in children up to a year after initial infection with Covid-19, finds a new study led by UCL researchers.

access_time Embargo lifts in 2 days
Embargo will expire: 5-Dec-2022 5:00 AM EST Released to reporters: 2-Dec-2022 5:50 PM EST

A reporter's PressPass is required to access this story until the embargo expires on 5-Dec-2022 5:00 AM EST The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 2-Dec-2022 4:45 PM EST
Fred Hutch at ASH: Global insights on AML outcomes, COVID-19 and cancer, CD19 CAR T-cell therapy updates, latest on precision oncology — and more
Fred Hutchinson Cancer Center

SEATTLE — Dec. 1, 2022 — The 64th Annual Meeting and Exposition of the American Society of Hematology (ASH) will take place virtually and in person Dec. 10-13 in New Orleans, Louisiana.

access_time Embargo lifts in 2 days
Embargo will expire: 5-Dec-2022 11:00 AM EST Released to reporters: 2-Dec-2022 3:05 PM EST

A reporter's PressPass is required to access this story until the embargo expires on 5-Dec-2022 11:00 AM EST The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: Where did Omicron come from?
Released: 2-Dec-2022 10:50 AM EST
Where did Omicron come from?
Charité - Universitätsmedizin Berlin

First discovered a year ago in South Africa, the SARS-CoV-2 variant later dubbed “Omicron” spread across the globe at incredible speed.

Not for public release

Embargo will expire: 2-Dec-2022 12:15 AM EST Released to reporters: 29-Nov-2022 4:00 PM EST

A reporter's PressPass is required to access this story until the embargo expires on 2-Dec-2022 12:15 AM EST The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Not for public release

Embargo will expire: 5-Dec-2022 11:00 AM EST Released to reporters: 1-Dec-2022 8:00 PM EST

A reporter's PressPass is required to access this story until the embargo expires on 5-Dec-2022 11:00 AM EST The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 1-Dec-2022 7:55 PM EST
Immune T cell defence is coping with COVID-19 variants of concern – for now
University of Birmingham

Immune T cells are continuing to target the spike protein of SARS-CoV-2 variants of concern, although mutations are making some T cells less effective, according to new research.

Newswise: Experimental COVID-19 Vaccine Offers Long-term Protection Against Severe Disease
Released: 1-Dec-2022 2:30 PM EST
Experimental COVID-19 Vaccine Offers Long-term Protection Against Severe Disease
University of North Carolina School of Medicine

SARS-CoV-2 vaccines protected infant rhesus macaques against 1 severe lung disease after high dose challenge one year after vaccination.

29-Nov-2022 7:55 PM EST
Long COVID patients and those with other illnesses experience similar, negative lingering effects during the pandemic
University of California, Los Angeles (UCLA), Health Sciences

Long COVID patients can experience many of the same lingering negative effects on their physical, mental, and social well-being as those experienced by people who become ill with other, non-COVID illnesses.


Showing results

110 of 8398

close
2.14726